REFERENCES
- Roberts PF, Waller TA, Brinker TM, et al. Henoch–Schonlein purpura: a review article. South Med J. 2007;100:821–824.
- Kawasaki Y. The pathogenesis and treatment of pediatric Henoch–Schönlein purpura nephritis. Clin Exp Nephrol. 2011;15:648–657.
- Ha TS. The role of tumor necrosis factor-alpha in Henoch–Schonlein purpura. Pediatr Nephrol. 2005;20:149–153.
- Besbas N, Saatci U, Ruacan S, et al. The role of cytokines in Henoch–Schonlein purpura. Scand J Rheumatol. 1997;26:456–460.
- Del Vecchio GC, Penza R, Altomare M, et al. Cytokine pattern and endothelium damage markers in Henoch–Schönlein purpura. Immunopharmacol Immunotoxicol. 2008;30:623–629.
- Lin CY, Yang YH, Lee CC, et al. Thrombopoietin and interleukin-6 levels in Henoch–Schönlein purpura. J Microbiol Immunol Infect. 2006;39:476–482.
- Söylemezoglu O, Sultan N, Gursel T, et al. Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch–Schönlein purpura. Arch Dis Child. 1996;75:507–511.
- Ozaltin F, Besbas N, Uckan D, et al. The role of apoptosis in childhood Henoch–Schonlein purpura. Clin Rheumatol. 2003;22:265–267.
- De Mattia D, Penza R, Giordano P, et al. von Willebrand factor and factor XIII in children with Henoch–Schonlein purpura. Pediatr Nephrol. 1995;9:603–605.
- Brendel-Müller K, Hahn A, Schneppenheim R, Santer R. Laboratory signs of activated coagulation are common in Henoch–Schönlein purpura. Pediatr Nephrol. 2001;16:1084–1088.
- Yilmaz D, Kavakli K, Ozkayin N. The elevated markers of hypercoagulability in children with Henoch–Schönlein purpura. Pediatr Hematol Oncol. 2005;22:41–48.
- Topaloglu R, Bayrakci US, Cil B, et al. Henoch–Schonlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence? Rheumatol Int. 2008;28:935–937.
- Griffin JH, Fernández JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost. 2007;5(Suppl 1):73–80.
- Koarada S, Tsuneyoshi N, Haruta Y, et al. Effect of disease activity and corticosteroids on serum levels of soluble endothelial cell protein C receptor in patients with systemic lupus erythematosus. Mod Rheumatol. 2009;19:173–179.
- Thiyagarajan M, Cheng T, Zlokovic BV. Endothelial cell protein C receptor: role beyond endothelium? Circ Res. 2007;100:155–157.
- Gandrille S. Endothelial cell protein C receptor and the risk of venous thrombosis. Haematologica. 2008;93:812–816.
- Boomsma MM, Stearns-Kurosawa DJ, Stegeman CA, et al. Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis. Clin Exp Immunol. 2002;128:187–194.
- Kendirli T, Ince E, Ciftci E, et al. Soluble endothelial protein C receptor level in children with sepsis. Pediatr Hematol Oncol. 2009;26:432–438.
- Yalçindağ FN, Batioğlu F, Ozdemir O, et al. Soluble endothelial protein C receptor levels in Behçet patients with and without ocular involvement. Graefes Arch Clin Exp Ophthalmol. 2008;246:1603–1608.
- Keven K, Elmaci S, Sengul S, et al. Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation. Int Urol Nephrol. 2010;42:1093–1098.
- Bilgic A, Ozdemir FN, Bayraktar N, et al. Soluble endothelial protein C receptor: influence on arteriovenous fistula thrombosis development in hemodialysis patients. Am J Nephrol. 2007; 27:366–372.
- Uitte de Willige S, Van Marion V, Rosendaal FR, et al. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost. 2004;2:1305–1310.
- Sesin C, Yin X, Esmon CT, et al. Shedding of endothelial protein C receptor contributes to vascuopathy and renal injury in lupus: in vivo and in vitro evidence. Kidney Int. 2005;68:110–120.
- McCarthy HJ, Tizard EJ. Clinical practice: diagnosis and management of Henoch–Schönlein purpura. Eur J Pediatr. 2010;169:643–650.
- Tizard EJ, Hamilton-Ayres MJ. Henoch–Schonlein purpura. Arch Dis Child Educ Pract Ed. 2008;93:1–8.
- Besbas N, Erbay A, Saatçi U, et al. Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch–Schönlein purpura. Clin Exp Rheumatol. 1998;16:95–98.
- Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol. 2004;24:1374–1383.
- Ulu A, Egin Y, Akar N. The correlation between soluble endothelial protein c receptor (SEPCR) and tumor necrosis factor alpha (TNF-α) levels in vivo. Turk J Hematol. 2008;25:108–109.
- Diehl JL, Borgel D. Sepsis and coagulation. Curr Opin Crit Care. 2005;11:454–460.
- Azik F, Ertem M, Ileri T, et al. Relation of soluble endothelial protein C receptor and cytokines after allogenic hematopoietic stem cell transplantation. Clin Appl Thromb Hemost. 2011;17:94–99.
- Orhon FS, Ergun H, Egin Y, et al. Soluble endothelial protein C receptor levels in healthy population. J Thromb Thrombolysis. 2010;29:46–51.
- Stearns-Kurosawa DJ, Burgin C, Parker D, et al. Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations. Thromb Haemost. 2003;1:855–856.